Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41
Published February 14, 2024 · Recall initiated: February 1, 2024
Summary
FDA records drug Class II recall D-0318-2024, published February 14, 2024 and initiated February 1, 2024. Recalling firm: NATCO Pharma Limited; Status: Terminated; Reported quantity: 4260 bottles; Lot: Lot # 411987 Exp: 05/2025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- NATCO Pharma Limited
- Distributor
- Nationwide in the USA
- Lot
- Lot # 411987 Exp: 05/2025
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDALansoprazole Delayed-Release Capsules USP, 15 mg, Acid reducer 24 Hour, Treats Frequent Heartburn, 14 capsulesApril 17, 2024
- FDAMedline Remedy Clinical TREAT Antifungal Cream, 2% Miconazole Nitrate, Paraben Free, 4 FL OZ (118 mL) tube,February 14, 2024
- FDAPhenoxybenzamine Hydrochloride Capsules, USP 10mg, 100-count bottle, Rx only, Manufactured by: AmnealFebruary 14, 2024
- FDAFebuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging,February 14, 2024
- FDAHydrALAZINE Hydrochloride Tablets, USP, 10 mg, 100-count (10 x 10) per unit dose carton, Rx Only, DistributedFebruary 14, 2024
- FDAGlimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,February 14, 2024
Questions about this recall
Was Lansoprazole Delayed-Release Capsules USP, 15 mg, 14-count bottle, Manufactured by: Natco Pharma Limited Kothur- 509 228, India, Distributed by: Rising Pharma Holdings, Inc. East Brunswick, NJ. 08816. NDC 16571-742-41 recalled?
Yes. FDA published recall D-0318-2024 on February 14, 2024. Reported hazard: CGMP Deviations: Inadequate induction sealing on bottles, capsules were observed with bubbles on band seal, capsules with holes and spheres sticking to capsules. Also coding details were missing on one bottle.
What should I do if I have this product?
Voluntary: Firm initiated · Letter